Cargando…
Potential biomarkers uncovered by bioinformatics analysis in sotorasib resistant-pancreatic ductal adenocarcinoma
BACKGROUND: Mutant KRAS-induced tumorigenesis is prevalent in lung, colon, and pancreatic ductal adenocarcinomas. For the past 3 decades, KRAS mutants seem undruggable due to their high-affinity GTP-binding pocket and smooth surface. Structure-based drug design helped in the design and development o...
Autores principales: | Ramalingam, Prasanna Srinivasan, Priyadharshini, Annadurai, Emerson, Isaac Arnold, Arumugam, Sivakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310804/ https://www.ncbi.nlm.nih.gov/pubmed/37396909 http://dx.doi.org/10.3389/fmed.2023.1107128 |
Ejemplares similares
-
Bioinformatic evidences and analysis of putative biomarkers in pancreatic ductal adenocarcinoma
por: Gu, Yuan, et al.
Publicado: (2019) -
Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma
por: González-Borja, Iranzu, et al.
Publicado: (2021) -
Sotorasib: First Approval
por: Blair, Hannah A.
Publicado: (2021) -
Correction to: Sotorasib: First Approval
por: Blair, Hannah A.
Publicado: (2021) -
Uncovering Tumor‐Promoting Roles of Activin A in Pancreatic Ductal Adenocarcinoma
por: Yu, Seok‐Yeong, et al.
Publicado: (2023)